BMRN vs CMP · P/E 40, rev $2.85B vs rev $1.12B
Biomarin Pharmaceutical Inc (BMRN) versus Compass Minerals International Inc (CMP) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Compass Minerals International Inc (CMP) is a other industrial metals & mining company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported CMP revenue for 2024-09-30 was $1.12B. Net income was -$206.1M. Revenue was down 7.2% from 2023-09-30 to 2024-09-30. CMP currently screens at market cap $916.5M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CMP currently screens at market cap $916.5M.
Not investment advice. Open the BMRN and CMP stock pages for the full models.
Not investment advice.